Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
General Neurology
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
e.g. reactive pleiocytosis, in light of publication from
Schimdauer et al in Eur J Neurol 2025 Apr
Related Questions
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?
Is IVIG ever used to treat CNS neurosarcoidosis–related pain when the presentation is not consistent with peripheral neurosarcoid involvement?”
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
What is your approach to treatment when there is a multiple sclerosis reactivation while on natalizumab?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
What therapy do you recommend in situations where IV steroids and IVIg do not help patients with GABA-A encephalitis?
What are red flags in an evaluation for possible multiple sclerosis that should prompt workup for genetic/inherited conditions?
What are your vaccine recommendations while patients are on biologics?
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?